The Promising Role of Anti-Fibrotic Agent Halofuginone in Liver Fibrosis/Cirrhosis

doi 10.5772/intechopen.68641
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

Resolving the Fibrotic Niche of Human Liver Cirrhosis Using Single-Cell Transcriptomics

2019English

The Fibrosis-Cirrhosis Index (FCI) for Staging of Liver Fibrosis in Chronic Hepatitis C

Afro-Egyptian Journal of Infectious and Endemic Diseases
2016English

Anti-Fibrotic Effect of Bovine Colostrum in Carbon Tetrachloride-Induced Hepatic Fibrosis

Precision and Future Medicine
2017English

Pathology of Liver Cirrhosis in Patients With Cystic Fibrosis of the Pancreas

JAMA - Journal of the American Medical Association
Medicine
1963English

Role of NADPH Oxidases in Liver Fibrosis

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2014English

The Anti-Fibrotic Effect of Adenosine A2B Receptor Antagonism in a Mouse Model of Dermal Fibrosis

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Studies on Liver Fibrosis (Cirrhosis) Due to Schistosomiasis Japonica

Kurume Medical Journal
Medicine
1963English

The Value of MRI in the Diagnosis of Primary Biliary Cirrhosis and Assessment of Liver Fibrosis

PLoS ONE
Multidisciplinary
2015English

The Anti-Fibrotic Agent Pirfenidone Synergizes With Cisplatin in Killing Tumor Cells and Cancer-Associated Fibroblasts

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy